Home > Healthcare > Drug Device Combination > Therapeutic Systems > Facial Palsy Market
Facial Palsy Market size was valued at USD 2.7 billion in 2023 and is projected to grow at a CAGR of 4.7% between 2024 and 2032. Increasing prevalence of facial paralysis, rising awareness for early screening and diagnosis, and growing demand for facial reanimation surgeries is driving the growth in market. Additionally, availability of advanced therapeutical treatment options such as electrotherapy is also supporting the revenue growth in market.
Facial palsy, or facial paralysis, is a disorder marked by the absence of voluntary muscle control on one side of the face. High incidence of various facial paralysis conditions, including Bell's palsy and facial nerve injuries caused by trauma, as well as neurological disorders have surged the demand for facial palsy diagnosis and treatments, globally. According to July 2023 study published in National Centers for Biotechnology Information, bell’s palsy has an incidence of 10-40 per 100,000 people globally and it is recurrent in up to 10% of patients. Given the high incidence rate, there is a substantial global demand for both treatment and diagnosis of facial palsy, thus driving facial palsy market growth.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Facial Palsy Market Size in 2023: | USD 2.7 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 4.7% |
2032 Value Projection: | USD 4 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 190 |
Tables, Charts & Figures: | 247 |
Segments covered: | Type, Management Type, End User, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|